Compositions and methods for inducing migration by dendritic cells and an immune response
AssigneeUniversity of Miami
InventorGeoffrey William Stone
Life of this patent
Estimating the term…
Loading patent…
AssigneeUniversity of Miami
InventorGeoffrey William Stone
Estimating the term…
Compositions and methods of activating dendritic cells with LMP1 and LMP1-activated dendritic cell based compositions and methods are effective for dendritic cell therapy and provide an adjuvant function for vaccine administration. LMP1 or LMP1-CD40 chimeric protein may be used to activate and mature dendritic cells. LMP1 and LMP1-activated dendritic cells act as an adjuvant to enhance the cellular immune response. Also disclosed herein are kits for activating dendritic cells and for preparing a vaccine formulation. Administration of the dendritic cells transfected with LMP1 can induce an immune response against cancer or infection. The mature dendritic cells may comprise an antigen and at least one cytokine in addition to LMP1. Use of LMP1 or LMP1-CD40 provides a way to activate and mature dendritic cells that retain functional and migratory abilities without the side effects that result from maturing the dendritic cells using PGE2
A composition comprising dendritic cells transfected with a nucleic acid encoding LMP1, wherein the dendritic cells are capable of migrating towards lymph node chemokines, secreting IL-12, and activating T cells.
A method of activating dendritic cells and inducing their migration toward lymph node chemokines, comprising introducing into the dendritic cells a nucleic acid encoding a LMP1-CD40 chimeric protein in the presence of at least one cytokine.
A vaccine formulation for preventing or treating a disease or condition in a subject, the vaccine comprising a) mature dendritic cells into which a first nucleic acid encoding LMP1 was introduced in the presence of at least one cytokine, the dendritic cells further comprising a second nucleic acid encoding an antigen, wherein the dendritic cells are capable of migrating towards lymph node chemokines, secreting IL-12, and activating T cells;
A composition for inducing dendritic cell migration comprising:
(canceled)
A kit for activating dendritic cells, the kit comprising:
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
Dependencies are inferred from the claim text.